LTA4H rs2660845 association with montelukast response in early and late-onset asthma.

Leukotrienes play a central pathophysiological role in both paediatric and adult asthma. However, 35% to 78% of asthmatics do not respond to leukotriene inhibitors. In this study we tested the role of the LTA4H regulatory variant rs2660845 and age of asthma onset in response to montelukast in ethnic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cyrielle Maroteau, Antonio Espuela-Ortiz, Esther Herrera-Luis, Sundararajan Srinivasan, Fiona Carr, Roger Tavendale, Karen Wilson, Natalia Hernandez-Pacheco, James D Chalmers, Steve Turner, Somnath Mukhopadhyay, Anke-Hilse Maitland-van der Zee, Esteban G Burchard, Maria Pino-Yanes, Simon Young, Glenda Lassi, Adam Platt, Colin N A Palmer, PiCA Consortium
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/336ae4e495164e158dd79d9dc9b0ed2d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:336ae4e495164e158dd79d9dc9b0ed2d
record_format dspace
spelling oai:doaj.org-article:336ae4e495164e158dd79d9dc9b0ed2d2021-12-02T20:06:11ZLTA4H rs2660845 association with montelukast response in early and late-onset asthma.1932-620310.1371/journal.pone.0257396https://doaj.org/article/336ae4e495164e158dd79d9dc9b0ed2d2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0257396https://doaj.org/toc/1932-6203Leukotrienes play a central pathophysiological role in both paediatric and adult asthma. However, 35% to 78% of asthmatics do not respond to leukotriene inhibitors. In this study we tested the role of the LTA4H regulatory variant rs2660845 and age of asthma onset in response to montelukast in ethnically diverse populations. We identified and genotyped 3,594 asthma patients treated with montelukast (2,514 late-onset and 1,080 early-onset) from seven cohorts (UKBiobank, GoSHARE, BREATHE, Tayside RCT, PAGES, GALA II and SAGE). Individuals under montelukast treatment experiencing at least one exacerbation in a 12-month period were compared against individuals with no exacerbation, using logistic regression for each cohort and meta-analysis. While no significant association was found with European late-onset subjects, a meta-analysis of 523 early-onset individuals from European ancestry demonstrated the odds of experiencing asthma exacerbations by carriers of at least one G allele, despite montelukast treatment, were increased (odds-ratio = 2.92, 95%confidence interval (CI): 1.04-8.18, I2 = 62%, p = 0.0412) compared to those in the AA group. When meta-analysing with other ethnic groups, no significant increased risk of asthma exacerbations was found (OR = 1.60, 95% CI: 0.61-4.19, I2 = 85%, p = 0.342). Our study demonstrates that genetic variation in LTA4H, together with timing of asthma onset, may contribute to variability in montelukast response. European individuals with early-onset (≤18y) carrying at least one copy of rs2660845 have increased odd of exacerbation under montelukast treatment, presumably due to the up-regulation of LTA4H activity. These findings support a precision medicine approach for the treatment of asthma with montelukast.Cyrielle MaroteauAntonio Espuela-OrtizEsther Herrera-LuisSundararajan SrinivasanFiona CarrRoger TavendaleKaren WilsonNatalia Hernandez-PachecoJames D ChalmersSteve TurnerSomnath MukhopadhyayAnke-Hilse Maitland-van der ZeeEsteban G BurchardMaria Pino-YanesSimon YoungGlenda LassiAdam PlattColin N A PalmerPiCA ConsortiumPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0257396 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Cyrielle Maroteau
Antonio Espuela-Ortiz
Esther Herrera-Luis
Sundararajan Srinivasan
Fiona Carr
Roger Tavendale
Karen Wilson
Natalia Hernandez-Pacheco
James D Chalmers
Steve Turner
Somnath Mukhopadhyay
Anke-Hilse Maitland-van der Zee
Esteban G Burchard
Maria Pino-Yanes
Simon Young
Glenda Lassi
Adam Platt
Colin N A Palmer
PiCA Consortium
LTA4H rs2660845 association with montelukast response in early and late-onset asthma.
description Leukotrienes play a central pathophysiological role in both paediatric and adult asthma. However, 35% to 78% of asthmatics do not respond to leukotriene inhibitors. In this study we tested the role of the LTA4H regulatory variant rs2660845 and age of asthma onset in response to montelukast in ethnically diverse populations. We identified and genotyped 3,594 asthma patients treated with montelukast (2,514 late-onset and 1,080 early-onset) from seven cohorts (UKBiobank, GoSHARE, BREATHE, Tayside RCT, PAGES, GALA II and SAGE). Individuals under montelukast treatment experiencing at least one exacerbation in a 12-month period were compared against individuals with no exacerbation, using logistic regression for each cohort and meta-analysis. While no significant association was found with European late-onset subjects, a meta-analysis of 523 early-onset individuals from European ancestry demonstrated the odds of experiencing asthma exacerbations by carriers of at least one G allele, despite montelukast treatment, were increased (odds-ratio = 2.92, 95%confidence interval (CI): 1.04-8.18, I2 = 62%, p = 0.0412) compared to those in the AA group. When meta-analysing with other ethnic groups, no significant increased risk of asthma exacerbations was found (OR = 1.60, 95% CI: 0.61-4.19, I2 = 85%, p = 0.342). Our study demonstrates that genetic variation in LTA4H, together with timing of asthma onset, may contribute to variability in montelukast response. European individuals with early-onset (≤18y) carrying at least one copy of rs2660845 have increased odd of exacerbation under montelukast treatment, presumably due to the up-regulation of LTA4H activity. These findings support a precision medicine approach for the treatment of asthma with montelukast.
format article
author Cyrielle Maroteau
Antonio Espuela-Ortiz
Esther Herrera-Luis
Sundararajan Srinivasan
Fiona Carr
Roger Tavendale
Karen Wilson
Natalia Hernandez-Pacheco
James D Chalmers
Steve Turner
Somnath Mukhopadhyay
Anke-Hilse Maitland-van der Zee
Esteban G Burchard
Maria Pino-Yanes
Simon Young
Glenda Lassi
Adam Platt
Colin N A Palmer
PiCA Consortium
author_facet Cyrielle Maroteau
Antonio Espuela-Ortiz
Esther Herrera-Luis
Sundararajan Srinivasan
Fiona Carr
Roger Tavendale
Karen Wilson
Natalia Hernandez-Pacheco
James D Chalmers
Steve Turner
Somnath Mukhopadhyay
Anke-Hilse Maitland-van der Zee
Esteban G Burchard
Maria Pino-Yanes
Simon Young
Glenda Lassi
Adam Platt
Colin N A Palmer
PiCA Consortium
author_sort Cyrielle Maroteau
title LTA4H rs2660845 association with montelukast response in early and late-onset asthma.
title_short LTA4H rs2660845 association with montelukast response in early and late-onset asthma.
title_full LTA4H rs2660845 association with montelukast response in early and late-onset asthma.
title_fullStr LTA4H rs2660845 association with montelukast response in early and late-onset asthma.
title_full_unstemmed LTA4H rs2660845 association with montelukast response in early and late-onset asthma.
title_sort lta4h rs2660845 association with montelukast response in early and late-onset asthma.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/336ae4e495164e158dd79d9dc9b0ed2d
work_keys_str_mv AT cyriellemaroteau lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT antonioespuelaortiz lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT estherherreraluis lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT sundararajansrinivasan lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT fionacarr lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT rogertavendale lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT karenwilson lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT nataliahernandezpacheco lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT jamesdchalmers lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT steveturner lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT somnathmukhopadhyay lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT ankehilsemaitlandvanderzee lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT estebangburchard lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT mariapinoyanes lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT simonyoung lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT glendalassi lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT adamplatt lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT colinnapalmer lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
AT picaconsortium lta4hrs2660845associationwithmontelukastresponseinearlyandlateonsetasthma
_version_ 1718375415722016768